Turn Therapeutics (TTRX) Payables (2024 - 2026)

Turn Therapeutics' Payables history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Payables changed N/A year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (changed N/A YoY), while the FY2025 annual figure was $2.9 million, up 338.91% from the prior year.
• Payables was $2.3 million for Q1 2026 at Turn Therapeutics, down from $2.9 million in the prior quarter.
• In the past five years, Payables ranged from a high of $2.9 million in Q4 2025 to a low of $667272.0 in Q4 2024.
• Historically, Payables has averaged $2.0 million across 3 years, with a median of $2.3 million in 2025.
• Biggest YoY gain for Payables was 338.91% in 2025; the steepest drop was 338.91% in 2025.
• A 3-year view of Payables shows it stood at $667272.0 in 2024, then surged by 338.91% to $2.9 million in 2025, then decreased by 20.95% to $2.3 million in 2026.
• The last three Payables figures came in at $2.3 million (Q1 2026), $2.9 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.